Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.47 |
| ▸ | CA1 | P00915 | 2/20 | 0.47 |
| ▸ | CA2 | P00918 | 2/20 | 0.47 |
| ▸ | CA9 | Q16790 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | MDM4 | O15151 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.47 |
| ▸ | CA5A | P35218 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30291836 | 1.00 | TYR (0.56) | TYRALDH1A1HDAC4HDAC8CA1 | |
| SCHEMBL8406756 | 0.88 | TYR (0.44) | TYRALDH1A1HDAC4HDAC8CA1 | |
| SCHEMBL29756201 | 0.83 | ALDH1A1 (0.50) | TYRALDH1A1CA1CA2CA9 | |
| SCHEMBL31124696 | 0.83 | ALDH1A1 (0.48) | TYRALDH1A1CA1CA2CA9 | |
| SCHEMBL2263076 | 0.83 | ALDH1A1 (0.48) | TYRALDH1A1CA1CA2CA9 | |
| SCHEMBL11467711 | 0.82 | TYR (0.45) | TYRALDH1A1HDAC4HDAC8CA1 | |
| Benzene SCHEMBL28222842 | 0.82 | UNG (0.44) | TYRALDH1A1CA1CA2CA9 | |
| SCHEMBL2935867 | 0.80 | CCNB2 (0.55) | TYRALDH1A1HDAC4HDAC8CA1 | |
| SCHEMBL2935869 | 0.80 | CCNB2 (0.55) | TYRALDH1A1HDAC4HDAC8CA1 | |
| SCHEMBL4099672 | 0.80 | HDAC4 (0.53) | TYRALDH1A1HDAC4HDAC8CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 224 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025090929-A1 | APPARATUS, SYSTEMS, AND METHODS FOR DETECTING HYPOGLYCEMIA | THE TRUSTEES OF INDIANA UNIVERSITY (US) | 2025-05-01 | — | — | WO | claimed |
| JP-4754142-B2 | — | — | 2011-08-24 | — | — | JP | claimed |
| US-6723883-B1 | REACTING A BENZALDEHYDE COMPOUND WITH AN ALKANALDEHYDE; CASCADE SYSTEM | BASF AKTIENGESELLSCHAFT (DE) | 2004-04-20 | — | — | US | claimed |
| EP-1220824-B1 | CONTINUOUS METHOD FOR PRODUCTION OF CINNAMALDEHYDE AND DIHYDROCINNAMALDEHYDE DERIVATIVES | BASF AG (DE) | 2004-02-11 | — | — | EP | claimed |
| EP-1220824-A1 | CONTINUOUS METHOD FOR PRODUCTION OF CINNAMALDEHYDE AND DIHYDROCINNAMALDEHYDE DERIVATIVES | BASF AKTIENGESELLSCHAFT (DE) | 2002-07-10 | — | — | EP | claimed |
| US-6380197-B1 | FOR TREATING AND PREVENTING A PLETHORA OF DISEASES INCLUDING DIABETES | AVENTIS PHARMA S. A. (FR) | 2002-04-30 | — | — | US | claimed |
| WO-2001027061-A1 | CONTINUOUS METHOD FOR PRODUCTION OF CINNAMALDEHYDE AND DIHYDROCINNAMALDEHYDE DERIVATIVES | BASF AKTIENGESELLSCHAFT (DE) | 2001-04-19 | — | — | WO | claimed |
| EP-1001943-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | Aventis Pharma S.A. (FR) | 2000-05-24 | — | — | EP | claimed |
| WO-1999003843-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | RHONE-POULENC RORER S.A. (FR) | 1999-01-28 | — | — | WO | claimed |
| EP-4103557-B1 | MONOACYLGLYCEROL LIPASE MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2026-02-18 | — | — | EP | disclosed |
| EP-4692289-A1 | PERFUME COMPOSITION AND ALICYCLIC ALCOHOL COMPOSITION | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-12502378-B2 | Monoacylglycerol lipase modulators for use in autism spectrum disorders | JANSSEN PHARMACEUTICA NV (BE) | 2025-12-23 | — | — | US | disclosed |
| EP-4180415-B1 | ALIPHATIC DIAMINE ISOMERIZATION METHOD, DIISOCYANATE PRODUCTION METHOD, POLYURETHANE PRODUCTION METHOD, AND POLYURETHANE | MITSUBISHI GAS CHEMICAL CO (JP) | 2025-11-26 | — | — | EP | disclosed |
| US-20250312504-A1 | VOLATILE COMPOSITION DISPENSER FOR COMPOSITIONS COMPRISING A META-(C1-C4 ALKOXY) SALICYLALDEHYDE | THE PROCTER & GAMBLE COMPANY | 2025-10-09 | — | — | US | disclosed |
| US-4415572-A | CARDIOTONIC AND INOTROPIC AGENTS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1983-11-15 | — | — | US | disclosed |
| US-4374149-A | HYPOTENSIVE AGENT AND VASODILATOR | STERLING DRUG INC. (US) | 1983-02-15 | — | — | US | disclosed |
| EP-0064690-A1 | Process for the preparation of substituted benzaldehydes | BAYER AG (DE) | 1982-11-17 | — | — | EP | disclosed |
| US-4329495-A | USEFUL AS ANALGESICS OR ANTICONVULSANTS, CHIRAL 2-(2-BENZYL-3-MERCAPTOPROPIONYLAMINO)-THIOBUTYRIC ACIDS, OR ALKANOL DERIVATIVES | PFIZER INC. (US) | 1982-05-11 | — | — | US | disclosed |
| US-4304790-A | 2-(Alkylthio, alkylsulfinyl or alkylsulfonyl)-4-[2-anilinoalkylamino)-1-hydroxyethyl]phenols and derivatives thereof | SCHERING CORPORATION (US) | 1981-12-08 | — | — | US | disclosed |
| US-4208536-A | PROMOTERS COMPRISING AROMATIC ALDEHYDES OR ACETALS OR A BENZOHYDROL | RHONE-POULENC INDUSTRIES (FR) | 1980-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12502378-B2 | Monoacylglycerol lipase modulators for use in autism spectrum disorders | LIPC, LPL, MGLL | TYR 3661/4885ALDH1A1 266/4885HDAC4 1024/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.